Accurate results
for patient care
Laboratory medicine and in vitro diagnostics

JCTLM Database: higher-order reference materials, methods and services

Details : C16RMP2R - UPLC-tandem mass spectrometry method for analysis of amyloid beta 1-40 in human CSF

Type (acronym)rmp
Typereference measurement procedure
Unique Nomination NumberC16RMP2R
Analyte Nameamyloid beta 1-40
IUPAC IFCC NumberAmyloid beta 1-40
Method capable of Traceability of Analyte to SI or Defined ProcedureSI
Applicable Matriceshuman CSF, frozen
NameUPLC-tandem mass spectrometry method for analysis of amyloid beta 1-40 in human CSF
Organization that developed Validated MethodBiomarker Research Laboratory, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA
Measurement Techniques Usedliquid chromatography tandem mass spectrometry, solid phase extraction
QuantityMass concentration
From (0)200
To (0)20000
Unit (0)pg/mL
From (1)17.4
To (1)1085.6
Unit (1)pg/mL
Level of Confidence (%)95%
Peer Reviewed PublicationQualification of a surrogate matrix-based absolute quantification method for Amyloid-beta 42 in human cerebrospinal fluid using 2D UPLC-tandem mass spectrometry, Korecka M. et al, ''Journal of Alzheimer's Disease, 2014, 41(2), 441-451 Analytical and clinical performance of Amyloid-beta peptides measurements in CSF of ADNIGO/2 participants by an LC-MS/MS Reference Method, Korecka M. et al, Clinical Chemistry, 2020, 66(4), 587-597 Analytical and clinical performance of amyloid beta peptides measurement in CSF of ADNIGO and ADNI2 participants by an UPLC-MS-MS reference method, Korecka M., Poster for 2018 AAIC, Alzheimer's and Dementia'', 2018, 14(7), 378
Comments to be published via JCTLM DBThis reference measurement method was developed and validated by Biomarker Research Laboratory, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA
Analyte Category NameProteins
Non-CCQM Key Comparison ReportCommutability study - Amyloid beta 42 adjusted methods- this project focused not only on comparison of Ab42 between immunoassays: Euroimmune, Fujirebio, Roche and mass spec (UPenn) after adjustment to Ab42 CRMs, but also included analysis of Abeta 40. Data are still under review so official or published report is not available.
Non-CCQM Key Comparison Report Hyperlink
Measurement principle/techniqueLiquid chromatography mass spectrometry